The pharma industry in India continues to grow rapidly and as it does the regulatory environment continues to shift. With over thirty years experience in pharma Tapan Ray has a broad overview of ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

The industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues to evolve, with significant ramifications for new pharmaceutical launches.

Multinational companies are shifting production to India, signaling a changing ... these trends are contributing to the rise of India's small-molecule pharmaceutical research industry and ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

The rise of LSHC GCCs in India is driven by the country’s vast technology talent pool, cost efficiencies, and a dynamic business environment fostering research, innovation, and operational excellence.

A study linking Indian generic drugs to a higher risk of serious side effects in the US has spurred backlash from the Indian ...

Indian pharmaceutical CDMOs are anticipated to encounter minimal disruptions from the proposed US tariffs of 10-25 per cent.